8X8 INC /DE/ Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
8 X8 Inc /De/ quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q1 2011 to Q3 2024.
  • 8 X8 Inc /De/ Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $64.6M, a 5.74% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $64.6M +$3.5M +5.74% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $59.2M -$5.75M -8.85% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $59M -$3.33M -5.34% Mar 31, 2024 10-Q 2024-11-06
Q4 2023 $63M +$9.23M +17.2% Dec 31, 2023 10-Q 2024-02-01
Q3 2023 $61.1M +$2.72M +4.66% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $65M +$9.51M +17.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $62.3M +$4.91M +8.55% Mar 31, 2023 10-K 2024-05-21
Q4 2022 $53.8M +$5.37M +11.1% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $58.3M +$7.17M +14% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $55.4M +$5.69M +11.4% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $57.4M +$6.25M +12.2% Mar 31, 2022 10-K 2023-05-25
Q4 2021 $48.4M -$1.96M -3.89% Dec 31, 2021 10-Q 2022-02-03
Q3 2021 $51.2M +$8.21M +19.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $49.8M +$9.18M +22.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $51.2M +$13.3M +35.3% Mar 31, 2021 10-K 2022-05-27
Q4 2020 $50.4M +$13M +34.8% Dec 31, 2020 10-Q 2021-01-29
Q3 2020 $43M +$12.2M +39.8% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $40.6M +$17.2M +73.7% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $37.8M +$17.6M +87.4% Mar 31, 2020 10-K 2021-05-17
Q4 2019 $37.4M +$18.3M +96.1% Dec 31, 2019 10-Q 2020-02-05
Q3 2019 $30.7M +$11.9M +62.9% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $23.4M +$5.64M +31.8% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $20.2M +$3.89M +23.8% Mar 31, 2019 10-K 2020-05-19
Q4 2018 $19.1M +$1.13M +6.31% Dec 31, 2018 10-Q 2019-01-30
Q3 2018 $18.9M +$3.69M +24.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $17.7M +$3.25M +22.4% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $16.3M +$2.03M +14.2% Mar 31, 2018 10-K 2019-05-21
Q4 2017 $17.9M +$4.87M +37.2% Dec 31, 2017 10-Q 2018-02-01
Q3 2017 $15.2M +$3.52M +30.2% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $14.5M +$2.94M +25.5% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $14.3M +$3.19M +28.9% Mar 31, 2017 10-K 2018-05-30
Q4 2016 $13.1M +$3.14M +31.7% Dec 31, 2016 10-Q 2017-02-08
Q3 2016 $11.7M +$1.53M +15.1% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $11.5M +$3.5M +43.5% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $11.1M +$4.43M +66.7% Mar 31, 2016 10-K 2017-05-30
Q4 2015 $9.93M +$2.69M +37.2% Dec 31, 2015 10-Q 2016-02-01
Q3 2015 $10.1M +$2.87M +39.5% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $8.04M +$2.09M +35.2% Jun 30, 2015 10-Q 2015-08-03
Q1 2015 $6.64M +$1.14M +20.7% Mar 31, 2015 10-K/A 2016-07-01
Q4 2014 $7.23M +$2.06M +39.9% Dec 31, 2014 10-Q 2015-01-26
Q3 2014 $7.27M +$2.58M +55.1% Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $5.95M +$2.35M +65.4% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $5.5M +$1.62M +41.8% Mar 31, 2014 10-K 2015-05-29
Q4 2013 $5.17M +$1.56M +43.4% Dec 31, 2013 10-Q 2014-01-31
Q3 2013 $4.69M +$533K +12.8% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $3.6M +$758K +26.7% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 $3.88M +$1.6M +70.3% Mar 31, 2013 10-K 2014-05-27
Q4 2012 $3.61M +$1.69M +88.1% Dec 31, 2012 10-Q 2013-01-25
Q3 2012 $4.15M +$2.36M +131% Sep 30, 2012 10-Q 2012-10-26
Q2 2012 $2.84M +$1.77M +165% Jun 30, 2012 10-Q 2012-07-24
Q1 2012 $2.28M +$1.42M +164% Mar 31, 2012 10-K 2013-05-28
Q4 2011 $1.92M Dec 31, 2011 10-Q 2012-01-23
Q3 2011 $1.8M Sep 30, 2011 10-Q 2011-11-01
Q2 2011 $1.07M Jun 30, 2011 10-Q 2011-07-22
Q1 2011 $863K Mar 31, 2011 10-K 2012-05-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.